Literature DB >> 29244075

The athlete's heart is a proarrhythmic heart, and what that means for clinical decision making.

Hein Heidbuchel1.   

Abstract

Recurring questions when dealing with arrhythmias in athletes are about the cause of the arrhythmia and, more importantly, about the eligibility of the athlete to continue sports activities. In essence, the relation between sports and arrhythmias can be understood along three lines: sports as arrhythmia trigger on top of an underlying problem, sports as arrhythmic substrate promotor, or sports as substrate inducer. Often, there is no sharp divider line between these entities. The athlete's heart, a heart that adapts so magically to cope with the demands of exercise, harbours many structural and functional changes that by themselves predispose to arrhythmia development, at the atrial, nodal and ventricular levels. In essence, the athlete's heart is a proarrhythmic heart. This review describes the changes in the athlete's heart that are related to arrhythmic expression and focuses on what this concept means for clinical decision making. The concept of the athlete's heart as a proarrhythmic heart creates a framework for evaluation and counselling of athletes, yet also highlights the difficulty in predicting the magnitude of associated risk. The management uncertainties are discussed for specific conditions like extreme bradycardic remodelling, atrioventricular nodal reentrant tachycardia, atrial fibrillation and flutter, and ventricular arrhythmias.

Entities:  

Mesh:

Year:  2018        PMID: 29244075     DOI: 10.1093/europace/eux294

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Vectorcardiogram in athletes: The Sun Valley Ski Study.

Authors:  Jason A Thomas; Erick A Perez-Alday; Allison Junell; Kelley Newton; Christopher Hamilton; Yin Li-Pershing; David German; Aron Bender; Larisa G Tereshchenko
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-11-07       Impact factor: 1.468

2.  Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.

Authors:  Marina Cerrone; Grecia M Marrón-Liñares; Chantal J M van Opbergen; Sarah Costa; Mimount Bourfiss; Marta Pérez-Hernández; Florencia Schlamp; Fabian Sanchis-Gomar; Kabir Malkani; Kamelia Drenkova; Mingliang Zhang; Xianming Lin; Adriana Heguy; Birgitta K Velthuis; Niek H J Prakken; Andre LaGerche; Hugh Calkins; Cynthia A James; Anneline S J M Te Riele; Mario Delmar
Journal:  Eur Heart J       Date:  2022-03-21       Impact factor: 35.855

Review 3.  Catheter Ablation of Life-Threatening Ventricular Arrhythmias in Athletes.

Authors:  Nicola Tarantino; Domenico G Della Rocca; Nicole S De Leon De La Cruz; Eric D Manheimer; Michele Magnocavallo; Carlo Lavalle; Carola Gianni; Sanghamitra Mohanty; Chintan Trivedi; Amin Al-Ahmad; Rodney P Horton; Mohamed Bassiouny; J David Burkhardt; G Joseph Gallinghouse; Giovanni B Forleo; Luigi Di Biase; Andrea Natale
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

4.  Cardiac desmosomal reserve: another piece of the exercise-induced arrhythmogenic cardiomyopathy puzzle?

Authors:  Kristina H Haugaa; Christine Rootwelt-Norberg
Journal:  Eur Heart J       Date:  2022-03-21       Impact factor: 29.983

5.  Amateur Athlete with Sinus Arrest and Severe Bradycardia Diagnosed through a Heart Rate Monitor: A Six-Year Observation-The Necessity of Shared Decision-Making in Heart Rhythm Therapy Management.

Authors:  Robert Gajda; Beat Knechtle; Anita Gębska-Kuczerowska; Jacek Gajda; Sebastian Stec; Michalina Krych; Magdalena Kwaśniewska; Wojciech Drygas
Journal:  Int J Environ Res Public Health       Date:  2022-08-19       Impact factor: 4.614

Review 6.  Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Athletes with Premature Ventricular Beats.

Authors:  Giulia Brunetti; Alberto Cipriani; Martina Perazzolo Marra; Manuel De Lazzari; Barbara Bauce; Chiara Calore; Ilaria Rigato; Francesca Graziano; Riccardo Vio; Domenico Corrado; Alessandro Zorzi
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.